Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 188 clinical trials
Occurrence of Dyskalemia With Treatment for Hypertension (OK)

Hypertension is a major public health issue associated with significant morbidities and mortality. Fixed-dose combination (FDC) pills, combining 2 or more classes of antihypertensive medications have considerable appeal because these drugs may reduce blood pressure more effectively and efficiently compared to monotherapy. However, because FDC medication causes 'dyskalemia', the occurrence …

amlodipine 5 mg
systolic blood pressure
telmisartan
antihypertensive drugs
blood pressure diastolic
  • 0 views
  • 24 Mar, 2022
  • 1 location
Angiotensin II in General Anesthesia

in patients with underlying essential hypertension and worse in patients taking Angiotensin Converting Enzyme Inhibitors (ACE) and Angiotensin Receptor Blockers (ARBs). Intravenous (IV

angiotensin converting enzyme
systolic blood pressure
angiotensin
angiotensin ii
angiotensin ii receptor antagonist
  • 0 views
  • 13 Jun, 2022
  • 1 location
Angiotensin II in Liver Transplantation (AngLT-1)

The purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.

angiotensin ii
  • 0 views
  • 21 Jul, 2022
  • 1 location
Angiotensin 1-7 in Obesity Hypertension

The purpose of this study is to find out if the investigational drug angiotensin-(1-7) improves cardiovascular health in patients with obesity and high blood pressure.

hypertensive medication
angiotensin
hypertension
body mass index
  • 115 views
  • 20 Jun, 2022
  • 1 location
Angiotensin Receptor Blockers in Aortic Stenosis (ARBAS)

This study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.

ejection fraction
stenosis
  • 0 views
  • 21 Apr, 2022
  • 2 locations
Metabolic Effects of Angiotensin-(1-7)

The overall purpose of this study is to learn more about the metabolic effects of angiotensin-(1-7) in the insulin resistant state associated with obesity. Pharmacologic approaches to increase

angiotensin
insulin sensitivity
type 2 diabetes mellitus
body mass index
prehypertension
  • 250 views
  • 21 Mar, 2022
  • 1 location
Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI (ARNiAMI)

This study examines the effect of Entresto on central hemodynamic parameters during exercise in patients with diastolic dysfunction following acute myocardial infarction. Half of the patients will receive Entresto and the other half will receive placebo.

angiotensin
acute myocardial infarction
valsartan
revascularisation
entresto
  • 0 views
  • 16 Feb, 2022
  • 1 location
Treatment of Angiotensin Converting Enzyme Inhibitor-induced Angioedema

Angiotensin Converting Enzyme (ACE) inhibitors are among the most important and widely prescribed drugs. They reduce the morbidity and mortality associated with high blood pressure, heart

  • 0 views
  • 12 Mar, 2022
  • 1 location
Renin and Renal Biomarker Response to Angiotensin II

Septic shock continues to exert a large economic burden around the world. Several developments have occurred that lead to the current study. First, angiotensin II is the newest FDA approved

vasopressor
  • 4 views
  • 10 Dec, 2021
  • 1 location
Angiotensin-(1-7) and Energy Expenditure in Human Obesity

The objective of this study is to better define the role of the hormone angiotensin-(1-7) in energy balance. We will test the overall hypothesis that angiotensin-(1-7) increases resting energy

body mass index
  • 103 views
  • 19 Jun, 2022
  • 1 location